In the meta-analysis by Omaña-Guzmán et al., which included 31 randomized clinical trials involving pediatric patients with MASLD and obesity, combined interventions of lifestyle modification and supplementation significantly reduced aminotransferase levels, insulin resistance indices, and BMI, although the overall clinical effect was moderate. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.